MEDIVATION, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 47 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-17: Reporting owner Hung David; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-17: Reporting owner Machado Clarence Patrick; Form 4; Security Stock Option (right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-17: Reporting owner Seely Lynn; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-17: Reporting owner Cohen Cheryl; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-17 | Hung David Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +155,000 155,000 owned after | $54.86 exercise price | 2012-12-18 | |
| 2012-12-17 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $54.86 exercise price | 2012-12-18 | |
| 2012-12-17 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $54.86 exercise price | 2012-12-18 | |
| 2012-12-17 | Cohen Cheryl Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $54.86 exercise price | 2012-12-18 | |
| 2012-10-30 | Bailey Gregory Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −101,900 0 owned after | $1.50 exercise price | 2012-11-01 | |
| 2012-10-30 | Bailey Gregory Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −60,000 0 owned after | $9.38 exercise price | 2012-11-01 | |
| 2012-10-30 | Bailey Gregory Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 0 owned after | $6.97 exercise price | 2012-11-01 | |
| 2012-10-30 | Bailey Gregory Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,999 5,001 owned after | $11.21 exercise price | 2012-11-01 | |
| 2012-10-30 | Bailey Gregory Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,498 12,502 owned after | $4.42 exercise price | 2012-11-01 | |
| 2012-10-30 | Bailey Gregory Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,374 20,626 owned after | $11.00 exercise price | 2012-11-01 | |
| 2012-10-02 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,332 0 owned after | $5.88 exercise price | 2012-10-03 | |
| 2012-10-02 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,068 93,932 owned after | $6.74 exercise price | 2012-10-03 | |
| 2012-10-01 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,500 3,332 owned after | $5.88 exercise price | 2012-10-03 | |
| 2012-09-27 | Adams Daniel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −23,038 0 owned after | $6.97 exercise price | 2012-09-27 | |
| 2012-09-27 | Adams Daniel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −60,000 0 owned after | $9.38 exercise price | 2012-09-27 | |
| 2012-09-25 | Adams Daniel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 23,038 owned after | $6.97 exercise price | 2012-09-27 | |
| 2012-09-07 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 44,416 owned after | $11.76 exercise price | 2012-09-11 | |
| 2012-07-25 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,400 91,600 owned after | $34.56 exercise price | 2012-07-27 | |
| 2012-07-16 | BLICKENSTAFF KIM D Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $94.96 exercise price | 2012-07-17 | |
| 2012-07-16 | Adams Daniel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $94.96 exercise price | 2012-07-17 | |
| 2012-07-16 | VERNON W ANTHONY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $94.96 exercise price | 2012-07-17 | |
| 2012-07-16 | Bailey Gregory Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $94.96 exercise price | 2012-07-17 | |
| 2012-07-02 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 64,416 owned after | $11.76 exercise price | 2012-07-05 | |
| 2012-06-15 | VERNON W ANTHONY Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −31,094 0 owned after | $4.45 exercise price | 2012-06-15 | |
| 2012-06-15 | Adams Daniel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,400 0 owned after | $3.75 exercise price | 2012-06-15 | |
| 2012-06-14 | VERNON W ANTHONY Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −43,206 31,094 owned after | $4.45 exercise price | 2012-06-15 | |
| 2012-06-14 | Adams Daniel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −38,100 24,400 owned after | $3.75 exercise price | 2012-06-15 | |
| 2012-06-14 | BLICKENSTAFF KIM D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,200 0 owned after | $3.75 exercise price | 2012-06-15 | |
| 2012-06-13 | VERNON W ANTHONY Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −27,600 74,300 owned after | $4.45 exercise price | 2012-06-15 | |
| 2012-06-13 | Adams Daniel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −981 14,019 owned after | $13.93 exercise price | 2012-06-15 | |
| 2012-06-13 | Adams Daniel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,499 7,501 owned after | $8.84 exercise price | 2012-06-15 | |
| 2012-06-13 | Adams Daniel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,020 62,500 owned after | $3.75 exercise price | 2012-06-15 | |
| 2012-06-13 | BLICKENSTAFF KIM D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,700 24,200 owned after | $3.75 exercise price | 2012-06-15 | |
| 2012-05-24 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,400 74,416 owned after | $11.76 exercise price | 2012-05-24 | |
| 2012-05-22 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −600 83,816 owned after | $11.76 exercise price | 2012-05-24 | |
| 2012-05-22 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,500 37,500 owned after | $13.47 exercise price | 2012-05-24 | |
| 2012-05-17 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,360 100,000 owned after | $21.17 exercise price | 2012-05-21 | |
| 2012-05-14 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −35,640 114,360 owned after | $21.17 exercise price | 2012-05-16 | |
| 2012-05-14 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 84,416 owned after | $11.76 exercise price | 2012-05-16 | |
| 2012-03-08 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 94,416 owned after | $11.76 exercise price | 2012-05-01 | |
| 2012-03-08 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −66,000 0 owned after | $3.60 exercise price | 2012-03-12 | |
| 2012-03-08 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 35,000 owned after | $18.77 exercise price | 2012-03-12 | |
| 2012-03-08 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 104,416 owned after | $11.76 exercise price | 2012-03-12 | |
| 2012-02-08 | BLICKENSTAFF KIM D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,300 41,900 owned after | $3.75 exercise price | 2012-02-09 | |
| 2012-02-08 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,193 114,416 owned after | $11.76 exercise price | 2012-02-09 | |
| 2012-02-07 | BLICKENSTAFF KIM D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,700 48,200 owned after | $3.75 exercise price | 2012-02-09 | |
| 2012-02-07 | Machado Clarence Patrick Officer (Chief Business Officer and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,391 133,609 owned after | $11.76 exercise price | 2012-02-09 |